Table A3.
Hydroxychloroquine + Azithromycin n = 152* |
Hydroxychloroquine n = 152* |
Placebo n = 152* |
|
---|---|---|---|
Asymptomatic day one and: | |||
Symptomatic day seven | 8 of 78 (10·3%, 4·5–19·2%) | 9 of 78 (11·5%, 5·4–20·1%) | 13 of 85 (15·3%, 8·4–24·7%) |
Symptomatic day 14 | 3 of 79 (3·8%, 0·8–10·7%) | 3 of 77 (3·9%, 0·8–11·0%) | 4 of 84 (4·8%, 1·3–11·7%) |
Symptomatic day 21 | 4 of 78 (5·1%, 1·4–12·6%) | 2 of 77 (2·6%, 0·3–9·1%) | 2 of 85 (2·4%, 0·3–8·2%) |
Symptomatic day one and: | |||
Asymptomatic day seven | 56 of 70 (80·0%, 68·7–88·6%) | 55 of 69 (79·7%, 68·3–88·4%) | 52 of 59 (88·1%, 77·1–95·1%) |
Asymptomatic day 14 | 66 of 69 (95·7%, 87·8–99·1%) | 64 of 69 (92·8%, 83·9–97·6%) | 58 of 60 (96·7%, 88·5–99·6%) |
Asymptomatic day 21 | 67 of 69 (97·1%, 89·9–99·6%) | 68 of 69 (98·6%, 92·2–100·0%) | 56 of 60 (93·3%, 83·8–98·2%) |